Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nivolumab-induced Myositis and Myocarditis with Positive Anti-titin Antibody and Anti-voltage-gated Potassium Channel Kv1.4 Antibody. | Intern Med | 2022 | 35314545 | PubTator, text mining | PubMed |
| Socio-Economic Burden of Myasthenia Gravis: A Cost-of-Illness Study in Bulgaria. | Front Public Health | 2022 | 35309194 | PubTator, text mining | PubMed |
| Autonomic dysfunction detected by skin sympathetic response in Lambert-Eaton myasthenic syndrome: a case report. | BMC Neurol | 2022 | 35305594 | PubTator, text mining | PubMed |
| Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies. | Eur J Transl Myol | 2022 | 35302338 | PubTator, text mining | PubMed |
| Lyn Phosphorylates and Controls ROR1 Surface Dynamics During Chemotaxis of CLL Cells. | Front Cell Dev Biol | 2022 | 35295854 | PubTator, text mining | PubMed |
| Regulatory B Cells Are Decreased and Functionally Impaired in Myasthenia Gravis Patients. | Front Neurol | 2022 | 35295834 | PubTator, text mining | PubMed |
| Autoimmune Neurological Disorders with IgG4 Antibodies: a Distinct Disease Spectrum with Unique IgG4 Functions Responding to Anti-B Cell Therapies. | Neurotherapeutics | 2022 | 35290608 | PubTator, text mining | PubMed |
| Early-Onset Myasthenia Gravis Following COVID-19 Vaccination. | J Korean Med Sci | 2022 | 35289135 | PubTator, text mining | PubMed |
| TREATMENT OF MYASTHENIA GRAVIS PATIENTS WITH COVID-19: REVIEW OF THE LITERATURE. | Acta Clin Croat | 2022 | 35282492 | PubTator, text mining | PubMed |
| The Epidemiology and Phenotypes of Ocular Manifestations in Childhood and Juvenile Myasthenia Gravis: A Review. | Front Neurol | 2022 | 35280301 | PubTator, text mining | PubMed |
| Ageing and exercise-induced motor unit remodelling. | J Physiol | 2022 | 35278221 | PubTator, text mining | PubMed |
| Clinical Significance of OX40 and OX40 Ligand in the Peripheral Blood of Patients with Myasthenia Gravis. | J Immunol Res | 2022 | 35265719 | PubTator, text mining | PubMed |
| Hearing Loss and Sixth Cranial Nerve Paresis after COVID-19. | Eur J Case Rep Intern Med | 2022 | 35265560 | PubTator, text mining | PubMed |
| Molecular Docking as a Therapeutic Approach for Targeting Cancer Stem Cell Metabolic Processes. | Front Pharmacol | 2022 | 35264950 | PubTator, text mining | PubMed |
| Eculizumab versus rituximab in generalised myasthenia gravis. | J Neurol Neurosurg Psychiatry | 2022 | 35246490 | PubTator, text mining | PubMed |
| Spotlight on MuSK positive myasthenia gravis: clinical characteristics, treatment and outcomes. | BMC Neurol | 2022 | 35246057 | PubTator, text mining | PubMed |
| Effects of Androgen Excess-Related Metabolic Disturbances on Granulosa Cell Function and Follicular Development. | Front Endocrinol (Lausanne) | 2022 | 35237237 | PubTator, text mining | PubMed |
| Neurologic Toxicity of Immune Checkpoint Inhibitors: A Review of Literature. | Front Pharmacol | 2022 | 35237154 | PubTator, text mining | PubMed |
| Preserved stem cell content and innervation profile of elderly human skeletal muscle with lifelong recreational exercise. | J Physiol | 2022 | 35229299 | PubTator, text mining | PubMed |
| Early Flare-Ups of Myasthenia Gravis After Thoracoscopic Thymectomy in a Patient Recently Receiving BNT162b2 mRNA COVID-19 Vaccination. | Cureus | 2022 | 35228930 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=47